☆ 4.5 Article

Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3

MOLECULAR BIOLOGY REPORTS (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression

Yuki Makino et al.

Summary: In hepatocellular carcinoma (HCC), CTGF-mediated tumor-stroma crosstalk activates STAT3 to promote HCC progression, and a positive feedback loop between STAT3 and CTGF is formed. This finding may serve as a potential therapeutic target for HCC treatment.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

JAK2/STAT3 inhibitor reduced 5-FU resistance and autophagy through ATF6-mediated ER stress

Lijuan Ma et al.

Summary: The study revealed that the JAK2/STAT3 pathway is involved in regulating ER stress, affecting 5-FU resistance and autophagy in AGS cells, mediated by ATF6. Targeting the JAK2/STAT3 pathway may be a potential approach to reduce 5-FU resistance in gastric cancer and enhance sensitivity to 5-FU. The research provides new insights into the molecular mechanisms underlying gastric cancer resistance to 5-FU.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2022)

Add to Collection

Article Cell Biology

Downregulation of HULC Induces Ferroptosis in Hepatocellular Carcinoma via Targeting of the miR-3200-5p/ATF4 Axis

Lulu Guan et al.

Summary: This study found that knockdown of HULC increases ferroptosis and oxidative stress in liver cancer cells. They also identified changes in certain miRNAs in cells treated with HULC siRNA, with HULC acting as a ceRNA of miR-3200-5p. miR-3200-5p regulates ferroptosis by targeting ATF4, leading to the inhibition of proliferation and metastasis in HCC cells.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Add to Collection

Article Oncology

Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity

Xueyao Wang et al.

Summary: Sorafenib is a first-line treatment for advanced hepatocellular carcinoma (HCC), but single-agent chemotherapy is not effective. Combination therapies have become a major trend for advanced HCC. STAT3 overexpression is involved in chemotherapy resistance and immune escape of HCC cells, making it a potential therapeutic target. Knocking down STAT3 enhances sorafenib-induced apoptosis and promotes anti-tumor immune responses.

CANCER LETTERS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma

Sumit Siddharth et al.

Summary: Hepatocellular carcinoma (HCC) is a malignant tumor with increasing incidence and mortality rates, and there is a lack of effective therapeutic options for advanced HCC. This study found that the combination of low-dose sorafenib and non-toxic dose of metformin can effectively inhibit the growth and migration potential of HCC cells, enhance the efficacy of sorafenib, and inhibit the MAPK/ERK/Stat3 signaling pathway. The results of in vivo studies also supported these findings.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Medicine, Research & Experimental

Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis

Ping Jin et al.

Summary: This study demonstrates that long-term exposure to metformin leads to metabolic adaptation in hepatocellular carcinoma cells, characterized by epithelial-mesenchymal transition and increased oxidative phosphorylation. TOMM34, a protein involved in mitochondrial transport, was found to promote tumor metastasis in response to metformin-induced metabolic stress. The study also shows that inhibiting the interaction between TOMM34 and ATP5B using a specific oxidative phosphorylation inhibitor increases sensitivity to metformin and suppresses tumor progression.

EMBO MOLECULAR MEDICINE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Tumor-Promoting Actions of HNRNP A1 in HCC Are Associated with Cell Cycle, Mitochondrial Dynamics, and Necroptosis

Biao Zhao et al.

Summary: This study reveals that HNRNP A1 plays a significant role in the progression and prognosis of HCC. High expression of HNRNP A1 promotes the proliferation, migration, and invasion of HCC cells, as well as accelerates tumor progression. Additionally, HNRNP A1 prevents the senescence process of HCC cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Multidisciplinary Sciences

Metformin administration is associated with enhanced response to transarterial chemoembolization for hepatocellular carcinoma in type 2 diabetes patients

Woo Jin Jung et al.

Summary: Metformin administration is associated with better initial response and lower local recurrence after TACE for single nodular HCC in patients with T2DM.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Medicine, Research & Experimental

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis

Ruize Gao et al.

Summary: The study reveals the critical role of YAP/TAZ in suppressing ferroptosis and establishing Sorafenib resistance in hepatocellular carcinoma (HCC). This highlights YAP/TAZ-based rewiring strategies as potential approaches to overcome HCC therapy resistance. The findings provide new insights into improving the efficacy of current therapies in cancer treatment.

EMBO MOLECULAR MEDICINE (2021)

Add to Collection

Letter Biochemistry & Molecular Biology

PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma

Xiao-Dong Yang et al.

Summary: PARP1 plays important roles in stem cell pluripotency and HCC sorafenib treatment resistance. Overexpression of PARP1 is closely associated with poor clinical outcome in HCC patients. Olaparib suppresses DNA damage repair signaling and the global pluripotent transcriptional network, enhancing sorafenib in eliminating HCC residual tumors.

MOLECULAR CANCER (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Metformin induces ferroptosis by targeting miR-324-3p/GPX4 axis in breast cancer

Yifeng Hou et al.

Summary: Metformin induces ferroptosis in breast cancer cells by upregulating miR-324-3p, leading to decreased cancer cell viability. The drug promotes ferroptosis by targeting the miR-324-3p/GPX4 axis, suggesting its potential as an anti-cancer agent.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)

Add to Collection

Article Cell Biology

Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth

Abigail S. Krall et al.

Summary: Mitochondrial respiration is essential for cell proliferation by generating biosynthetic precursors like aspartate. Inhibition of electron transport chain can deplete aspartate and impair ATF4 and mTORC1 activities. Adding exogenous asparagine can restore these activities and promote cell proliferation in the context of ETC inhibition.

CELL METABOLISM (2021)

Add to Collection

Review Oncology

Broadening horizons: the role of ferroptosis in cancer

Xin Chen et al.

Summary: Ferroptosis is an iron-dependent form of regulated cell death driven by excessive lipid peroxidation, and can be induced by various agents to suppress tumor growth while also potentially triggering inflammation-associated immunosuppression. The extent of ferroptosis's impact on tumor biology and its interactions with other signaling pathways are still under investigation.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC

Yueqi Zhang et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is closely associated with the global epidemics of obesity and type 2 diabetes mellitus (T2DM), and can progress to nonalcoholic steatohepatitis (NASH) leading to hepatocellular carcinoma (HCC). Metformin, a first-line drug for T2DM, may reduce risks for various cancers including HCC and protect against NASH-related HCC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Oncology

Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by Metformin

Se-Kyeong Jang et al.

Summary: Metformin inhibits mTORC1 activity by inducing the expression of ATF4, REDD1, and Sestrin2 independently of AMPK activation. Additionally, lapatinib enhances cell sensitivity to metformin, while knockdown of REDD1 and Sestrin2 reduces sensitivity to both metformin and lapatinib. These findings suggest a potential therapeutic value of the ATF4-induced REDD1 and Sestrin2 signaling pathway in mTORC1 inhibition.

BMC CANCER (2021)

Add to Collection

Review Biochemistry & Molecular Biology

New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway

Sheng-Kai Hsu et al.

Summary: Under metabolic stress conditions, such as hypoxia and glucose deprivation, an increase in the AMP:ATP ratio activates the AMP-activated protein kinase (AMPK) pathway, which modulates cellular metabolism and protects cells from degradation or pathogenic changes. Metformin, widely used in T2DM patients, activates the AMPK pathway to regulate blood sugar and may exert effects beyond diabetes treatment, including potential anticancer effects and modulation of nonapoptotic cell death pathways. The review also discusses possible antimetastatic and immunosuppressive effects of metformin, suggesting promising cancer prevention strategies for the future.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Oncology

Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer

Jingjing Yang et al.

Summary: This study demonstrates that metformin induces ferroptosis in an AMPK-independent manner to suppress tumor growth. Mechanistically, metformin increases the intracellular Fe2+ and lipid ROS levels by targeting the UFMylation process of SLC7A11. Additionally, combining metformin with the x(c)(-) inhibitor sulfasalazine synergistically induces ferroptosis and inhibits the proliferation of breast cancer cells.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Add to Collection

Review Medicine, Research & Experimental

Ferroptosis as a novel therapeutic target for cardiovascular disease

Xiaoguang Wu et al.

Summary: Cell death is a significant factor in cardiovascular disease pathophysiology. Ferroptosis, a regulated cell death form characterized by iron overload and lipid hydroperoxide accumulation, is closely associated with various diseases and plays critical roles in cardiomyopathy, myocardial infarction, ischemia/reperfusion injury, and heart failure. Targeting ferroptosis may offer potential novel therapeutic strategies for cardiovascular diseases.

THERANOSTICS (2021)

Add to Collection

Review Cell Biology

Mitochondria regulation in ferroptosis

Hai Wang et al.

EUROPEAN JOURNAL OF CELL BIOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Ferroptosis in Liver Diseases: An Overview

Martina Maria Capelletti et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Biochemistry & Molecular Biology

CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1

Junjie Xu et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects

Weiwei Tang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Article Genetics & Heredity

lncARSR promotes liver cancer stem cells expansion via STAT3 pathway

Cheng Yang et al.

GENE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

ER and Nutrient Stress Promote Assembly of Respiratory Chain Supercomplexes through the PERK-eIF2α Axis

Eduardo Balsa et al.

MOLECULAR CELL (2019)

Add to Collection

Article Medicine, General & Internal

Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling

Dongyao Wang et al.

EBIOMEDICINE (2019)

Add to Collection

Review Gastroenterology & Hepatology

Goals and targets for personalized therapy for HCC

Thomas Couri et al.

HEPATOLOGY INTERNATIONAL (2019)

Add to Collection

Article Gastroenterology & Hepatology

Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish

Sofia de Oliveira et al.

JOURNAL OF HEPATOLOGY (2019)

Add to Collection

Review Endocrinology & Metabolism

Metformin in cancer

Ritwika Mallik et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2018)

Add to Collection

Review Oncology

Role of ferroptosis in hepatocellular carcinoma

Jianhua Nie et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)

Add to Collection

Article Cell Biology

Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals

Pedro M. Quiros et al.

JOURNAL OF CELL BIOLOGY (2017)

Add to Collection

Review Oncology

Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis

C. Coyle et al.

ANNALS OF ONCOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Metallothionein-1G Facilitates Sorafenib Resistance Through Inhibition of Ferroptosis

Xiaofang Sun et al.

HEPATOLOGY (2016)

Add to Collection

Article Oncology

Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models

Abin You et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)

Add to Collection

Review Oncology

Hepatocellular carcinoma: From diagnosis to treatment

Miral Sadaria Grandhi et al.

SURGICAL ONCOLOGY-OXFORD (2016)

Add to Collection

Article Gastroenterology & Hepatology

Diabetes mellitus and metformin in hepatocellular carcinoma

Koji Fujita et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Add to Collection

Article Oncology

Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs

Chia-Chi Hsu et al.

ONCOLOGY REPORTS (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation

Kook Hwan Kim et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Add to Collection

Article Gastroenterology & Hepatology

Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

Hsiao-Ping Chen et al.

GUT (2013)

Add to Collection

Article Endocrinology & Metabolism

Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes

Y. Chen et al.

DIABETOLOGIA (2012)

Add to Collection

Article Biochemistry & Molecular Biology

Activating transcription factor 4 overexpression inhibits proliferation and differentiation of mammary epithelium resulting in impaired lactation and accelerated involution

R Bagheri-Yarmand et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.